| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.923 | 0.003 | 0.923 | Anticonvulsant | 0.737 0.005 CID_11666741 | ||
| 0.869 | 0.004 | 0.869 | Platelet aggregation inhibitor | 0.813 0.004 CID_11666741 | ||
| 0.845 | 0.003 | 0.845 | Platelet activating factor antagonist | 0.759 0.004 CID_11666741 | ||
| 0.789 | 0.002 | 0.789 | GABA receptor agonist | 0.642 0.003 CID_11666741 | ||
| 0.783 | 0.002 | 0.783 | Benzodiazepine agonist | 0.574 0.002 CID_11666741 | ||
| 0.755 | 0.002 | 0.755 | GABA A receptor antagonist | 0.501 0.003 CID_11666741 | ||
| 0.749 | 0.003 | 0.749 | GABA receptor antagonist | 0.496 0.003 CID_11666741 | ||
| 0.732 | 0.003 | 0.732 | GABA C receptor rho-3 antagonist | 0.625 0.005 CID_11666741 | ||
| 0.643 | 0.005 | 0.643 | Psychostimulant | 0.504 0.01 CID_11666741 | ||
| 0.431 | 0.004 | 0.431 | GABA A receptor agonist | 0.115 0.027 CID_11666741 | ||
| 0.327 | 0.004 | 0.327 | GABA C receptor rho-2 antagonist | 0.244 0.013 CID_11666741 | ||
| 0.316 | 0.011 | 0.316 | M18 aspartyl aminopeptidase inhibitor | 0.292 0.014 CID_11666741 | ||
| 0.42 | 0.128 | 0.42 | Antiinflammatory | |||
| 0.273 | 0.055 | 0.273 | Gastrin inhibitor | |||
| 0.201 | 0.015 | 0.201 | Topoisomerase II alpha inhibitor | 0.173 0.019 CID_11666741 | ||
| 0.182 | 0.008 | 0.182 | Purinergic P2 antagonist | |||
| 0.183 | 0.011 | 0.183 | GABA C receptor rho-1 antagonist | 0.125 0.036 CID_11666741 | ||
| 0.171 | 0.004 | 0.171 | Nicotinic acid receptor 1 agonist | 0.13 0.005 CID_11666741 | ||
| 0.17 | 0.021 | 0.17 | GABA C receptor antagonist | 0.12 0.052 CID_11666741 | ||
| 0.148 | 0.003 | 0.148 | Benzodiazepine antagonist | 0.082 0.005 CID_11666741 | ||
| 0.233 | 0.09 | 0.233 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.209 0.142 CID_11666741 | ||
| 0.144 | 0.005 | 0.144 | Purinergic P2X antagonist | |||
| 0.322 | 0.184 | 0.322 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.245 | 0.111 | 0.389 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.389 0.024 CID_11666741 | CID_11666741 | |
| 0.173 | 0.041 | 0.173 | Sodium channel (voltage-gated) blocker | |||
| 0.164 | 0.032 | 0.164 | Pregnane X receptor agonist | 0.135 0.085 CID_11666741 | ||
| 0.183 | 0.052 | 0.183 | Diuretic | |||
| 0.28 | 0.155 | 0.28 | MAP kinase kinase 6 inhibitor | |||
| 0.126 | 0.009 | 0.126 | Phosphodiesterase 1B inhibitor | 0.073 0.028 CID_11666741 | ||
| 0.121 | 0.006 | 0.121 | Phosphodiesterase 1C inhibitor | 0.08 0.02 CID_11666741 | ||
| 0.158 | 0.046 | 0.158 | Glutamate receptor antagonist | |||
| 0.117 | 0.007 | 0.117 | Phosphodiesterase 1A inhibitor | 0.066 0.029 CID_11666741 | ||
| 0.131 | 0.022 | 0.131 | Phosphodiesterase I inhibitor | 0.096 0.05 CID_11666741 | ||
| 0.112 | 0.005 | 0.112 | 5 Hydroxytryptamine 1B agonist | 0.105 0.006 CID_11666741 | ||
| 0.179 | 0.074 | 0.179 | LIM domain kinase 1 inhibitor | |||
| 0.153 | 0.048 | 0.153 | Topoisomerase II inhibitor | |||
| 0.197 | 0.096 | 0.197 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.126 | 0.025 | 0.126 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 CID_11666741 | ||
| 0.105 | 0.005 | 0.105 | Purinergic P2X7 antagonist | |||
| 0.108 | 0.01 | 0.108 | AMPA receptor antagonist | 0.083 0.016 CID_11666741 | ||
| 0.098 | 0.009 | 0.098 | Cholecystokinin A antagonist | |||
| 0.107 | 0.019 | 0.107 | MAP kinase kinase 8 inhibitor | |||
| 0.108 | 0.021 | 0.108 | Protein kinase B beta inhibitor | 0.104 0.023 CID_11666741 | ||
| 0.114 | 0.027 | 0.114 | Bromodomain-containing protein 2 inhibitor | |||
| 0.091 | 0.006 | 0.091 | Histamine H4 receptor antagonist | |||
| 0.223 | 0.139 | 0.223 | Immunomodulator | |||
| 0.148 | 0.065 | 0.148 | MAP kinase kinase 4 inhibitor | 0.143 0.076 CID_11666741 | ||
| 0.154 | 0.075 | 0.154 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.081 | 0.006 | 0.081 | GABA B receptor antagonist | 0.049 0.021 CID_11666741 | ||
| 0.111 | 0.036 | 0.111 | Polo-like kinase-1 inhibitor | |||
| 0.095 | 0.022 | 0.095 | 5 Hydroxytryptamine 1 agonist | |||
| 0.179 | 0.109 | 0.179 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.084 | 0.015 | 0.084 | Antidiuretic hormone antagonist | |||
| 0.079 | 0.012 | 0.079 | Cholecystokinin antagonist | |||
| 0.093 | 0.026 | 0.093 | Nav1.7 sodium channel blocker | |||
| 0.123 | 0.056 | 0.123 | DNA intercalator | 0.1 0.073 CID_11666741 | ||
| 0.094 | 0.029 | 0.094 | Glutamate (mGluR group I) antagonist | |||
| 0.116 | 0.053 | 0.116 | MAP kinase kinase kinase inhibitor | |||
| 0.179 | 0.117 | 0.179 | ErbB-1 antagonist | |||
| 0.128 | 0.067 | 0.128 | Protein kinase (CK1) delta inhibitor | |||
| 0.096 | 0.037 | 0.096 | Glutamate (mGluR) antagonist | |||
| 0.088 | 0.03 | 0.088 | Toll-Like receptor 7 antagonist | |||
| 0.076 | 0.019 | 0.076 | Phosphodiesterase II inhibitor | |||
| 0.069 | 0.013 | 0.069 | Bromodomain-containing protein 3 inhibitor | 0.052 0.03 CID_11666741 | ||
| 0.068 | 0.012 | 0.068 | Vasopressin 1 antagonist | |||
| 0.066 | 0.011 | 0.066 | Benzodiazepine inverse agonist | 0.045 0.037 CID_11666741 | ||
| 0.077 | 0.023 | 0.077 | MDM2 inhibitor | |||
| 0.115 | 0.061 | 0.115 | MAP kinase 13 inhibitor | 0.106 0.072 CID_11666741 | ||
| 0.069 | 0.019 | 0.069 | Phosphodiesterase 2A inhibitor | |||
| 0.086 | 0.038 | 0.086 | Polo-like kinase-2 inhibitor | |||
| 0.094 | 0.046 | 0.094 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.058 | 0.011 | 0.058 | Vasopressin 1A antagonist | |||
| 0.072 | 0.026 | 0.072 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.085 | 0.039 | 0.085 | 5 Hydroxytryptamine agonist | |||
| 0.065 | 0.019 | 0.065 | Glutamate (mGluR5) antagonist | |||
| 0.179 | 0.135 | 0.179 | RNA-directed DNA polymerase inhibitor | |||
| 0.065 | 0.025 | 0.065 | MAP kinase kinase 9 inhibitor | |||
| 0.089 | 0.049 | 0.089 | mTOR complex 2 inhibitor | 0.084 0.059 CID_11666741 | ||
| 0.141 | 0.105 | 0.141 | Antipruritic | |||
| 0.096 | 0.062 | 0.096 | Pim-1 kinase inhibitor | |||
| 0.042 | 0.011 | 0.083 | Benzodiazepine receptor peripheral-type antagonist | 0.083 0.004 CID_11666741 | CID_11666741 | |
| 0.061 | 0.031 | 0.061 | Bromodomain-containing protein 4 inhibitor | |||
| 0.098 | 0.068 | 0.098 | Hedgehog signaling inhibitor | |||
| 0.074 | 0.044 | 0.074 | Protein kinase B alpha inhibitor | |||
| 0.052 | 0.022 | 0.052 | Purinergic P2X4 antagonist | |||
| 0.089 | 0.06 | 0.089 | Falcipain 2 inhibitor | |||
| 0.155 | 0.126 | 0.155 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.094 | 0.066 | 0.094 | Creatine kinase inhibitor | 0.084 0.08 CID_11666741 | ||
| 0.077 | 0.049 | 0.077 | GABA B receptor agonist | |||
| 0.046 | 0.018 | 0.046 | AMPA 4 receptor antagonist | 0.038 0.031 CID_11666741 | ||
| 0.05 | 0.022 | 0.05 | Parathyroid hormone antagonist | 0.043 0.039 CID_11666741 | ||
| 0.09 | 0.063 | 0.09 | Falcipain inhibitor | |||
| 0.063 | 0.036 | 0.063 | Glutamate (mGluR1) antagonist | |||
| 0.059 | 0.032 | 0.059 | Toll-Like receptor 8 antagonist | |||
| 0.083 | 0.057 | 0.083 | T cell inhibitor | |||
| 0.039 | 0.015 | 0.039 | AMPA 1 receptor antagonist | |||
| 0.077 | 0.055 | 0.077 | MAP kinase kinase 7 inhibitor | |||
| 0.069 | 0.046 | 0.069 | Exportin-1 inhibitor | |||
| 0.114 | 0.092 | 0.114 | Sodium channel blocker | |||
| 0.045 | 0.024 | 0.045 | Alpha 1L adrenoreceptor agonist | |||
| 0.042 | 0.022 | 0.042 | MAP3K5 inhibitor | |||
| 0.098 | 0.079 | 0.098 | 5 Hydroxytryptamine 3A agonist | |||
| 0.106 | 0.089 | 0.106 | MAP kinase 12 inhibitor | |||
| 0.024 | 0.009 | 0.024 | Factor IX inhibitor | 0.017 0.014 CID_11666741 | ||
| 0.057 | 0.042 | 0.057 | Adenosine A1 receptor antagonist | 0.051 0.047 CID_11666741 | ||
| 0.055 | 0.041 | 0.055 | 5 Hydroxytryptamine 7 agonist | |||
| 0.084 | 0.072 | 0.084 | Antihistaminic | |||
| 0.028 | 0.017 | 0.028 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.124 | 0.113 | 0.124 | Hexokinase inhibitor | |||
| 0.082 | 0.072 | 0.082 | Potassium channel activator | |||
| 0.075 | 0.065 | 0.075 | Glycine receptor antagonist | |||
| 0.105 | 0.096 | 0.105 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.048 | 0.04 | 0.048 | Factor IXa inhibitor | |||
| 0.146 | 0.14 | 0.146 | Dyrk kinase inhibitor | |||
| 0.082 | 0.077 | 0.085 | Alcohol dehydrogenase inhibitor | 0.085 0.072 CID_11666741 | CID_11666741 | |
| 0.075 | 0.07 | 0.075 | Histamine antagonist | |||
| 0.042 | 0.038 | 0.042 | Farnesyltransferase inhibitor | |||
| 0.096 | 0.093 | 0.096 | Nav1.5 sodium channel blocker | |||
| 0.052 | 0.072 | 0.109 | Cyclin B3 inhibitor | 0.109 0.025 CID_11666741 | CID_11666741 | |
| 0.071 | 0.098 | 0.082 | NADH dehydrogenase inhibitor | 0.082 0.071 CID_11666741 | CID_11666741 | |
| 0.119 | 0.152 | 0.211 | Anesthetic general | 0.211 0.069 CID_11666741 | CID_11666741 | |
| 0.129 | 0.162 | 0.168 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.168 0.107 CID_11666741 | CID_11666741 | |
| 0.098 | 0.132 | 0.166 | Cytidine deaminase inhibitor | 0.166 0.064 CID_11666741 | CID_11666741 | |
| 0.088 | 0.131 | 0.124 | Interleukin 8 antagonist | 0.124 0.056 CID_11666741 | CID_11666741 | |
| 0.112 | 0.161 | 0.13 | MAP kinase 3 inhibitor | 0.13 0.106 CID_11666741 | CID_11666741 | |
| 0.066 | 0.136 | 0.087 | Protein kinase C zeta inhibitor | 0.087 0.071 CID_11666741 | CID_11666741 | |
| 0.065 | 0.146 | 0.092 | Electrolyte absorption antagonist | 0.092 0.071 CID_11666741 | CID_11666741 | |
| 0.07 | 0.235 | 0.116 | Cell wall synthesis inhibitor | 0.116 0.105 CID_11666741 | CID_11666741 | |
| 0.111 | 0.278 | 0.173 | MAP-kinase-activated kinase 5 inhibitor | 0.173 0.144 CID_11666741 | CID_11666741 | |
| 0.045 | 0.257 | 0.129 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.129 0.107 CID_11666741 | CID_11666741 | |
| 0.043 | 0.288 | 0.117 | Protein kinase C nu inhibitor | 0.117 0.096 CID_11666741 | CID_11666741 | |
| 0.027 | 0.331 | 0.096 | Protein kinase C mu inhibitor | 0.096 0.061 CID_11666741 | CID_11666741 | |
| 0.009 | 0.503 | 0.052 | Plasminogen activator inhibitor | 0.052 0.046 CID_11666741 | CID_11666741 | |
| 0.002 | 0.967 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.007 CID_11666741 | CID_11666741 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |